Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Merck & Co has appointed Dr Luciano Rossetti, formally professor of medicine and professor of molecular pharmacology at the Albert Einstein College of Medicine of Yeshiva University, as senior vice president and franchise head of the diabetes and obesity arm of Merck Research Laboratories.
Subscribe to our email newsletter
In this newly-created position, Dr Rossetti will have overall responsibility for scientific direction across the drug discovery and development process for Merck’s key therapeutic areas of diabetes and obesity. Dr Rossetti will report directly to Dr Peter Kim, president of Merck Research Laboratories (MRL).
During his 15 years at the Albert Einstein College of Medicine, Dr Rossetti, 49, held the Judy R. and Alfred A. Rosenberg Endowed Chair in Diabetes Research, and since 2002, he also served as the director of the Einstein Diabetes Research Center.
“Luciano Rossetti is a truly outstanding physician scientist whose work has had a major impact on our understanding of diabetes and obesity. We are delighted to bring a scientist of his stature to the MRL team,” Dr Kim said.
Dr Rossetti has made major contributions to the understanding of the biochemical and molecular mechanism mediating the sensing of nutrients and the role of leptin in the regulation of glucose and fat metabolism. He is an expert in the application of molecular genetics and pharmacological approaches to studies on appetite and metabolic control by the hypothalamus.